Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Future Oncology (London, England)|December 13, 2006
Pegfilgrastim: current and future perspectives in the treatment of chemotherapy-induced neutropeniaRiccardo Ricotta, Giulio Cerea, Ilaria Schiavetto, et al.Expert Review of Anticancer Therapy|April 1, 2020
Entrectinib for the treatment of metastatic NSCLC: safety and efficacyAndrea Sartore-Bianchi, Elio Gregory Pizzutilo, Giovanna Marrapese, et al.Future Oncology (London, England)|January 26, 2019
Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature reviewMaria Ida Abbate, Diego Luigi Cortinovis, Marcello Tiseo, et al.Human Vaccines & Immunotherapeutics|May 18, 2021
Immune checkpoint inhibitors for unresectable malignant pleural mesotheliomaGiulio Metro, Diego Signorelli, Elio G Pizzutilo, et al.Targeted Oncology|March 19, 2021
Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNAGiorgio Patelli, Caterina Vaghi, Federica Tosi, et al.Cancers|June 2, 2021
Liquid Biopsy for Small Cell Lung Cancer either De Novo or Transformed: Systematic Review of Different Applications and Meta-AnalysisElio Gregory Pizzutilo, Martino Pedrani, Alessio Amatu, et al.Cancer Research|May 19, 2023
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and ToxicityElio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.Oncotarget|September 11, 2020
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancerSimona Ruxandra Volovat, Tudor-Eliade Ciuleanu, Piotr Koralewski, et al.Journal of Medical Case Reports|February 2, 2021
Chemotherapy-induced myasthenic crisis in thymoma treated with primary chemotherapy with curative intent on mechanical ventilation: a case report and review of the literatureGiorgio Patelli, Katia Bencardino, Federica Tosi, et al.Anticancer Research|December 13, 2005
Treatment of metastatic neuroendocrine carcinomas based on WHO classificationSalvatore Artale, Laura Giannetta, Giulio Cerea, et al.Pageof 3